在异质网络中转移注意力 融合用于药物重新定位
IEEE journal of biomedical and health informatics
|October 28, 2024
概括
这项研究介绍了ATDR,一种新的计算药物重新定位方法,使用跨生物网络的注意力转移. ATDR提高了药物疾病关联预测,加速药物开发和复杂疾病治疗.
科学领域:
- 计算生物学是一种计算生物学.
- 药物发现 药物发现
- 生物信息学是一种生物信息学.
背景情况:
- 药物重新定位加速药物开发,减少复杂疾病的时间和成本.
- 异质网络融合改善了药物重新定位,但在特征表示和关联构建方面面临挑战.
- 现有的方法难以整合多样化的生物网络数据,以准确预测药物与疾病的关联.
研究的目的:
- 提出一种新的计算药物重新定位方法 (ATDR),以改进药物疾病关联预测.
- 解决药物特征表示和跨异质生物网络构建关联的挑战.
- 为了利用跨网络的注意力转移来提高预测准确性.
主要方法:
- 使用随机浏览生物网络的图形表示来描述药物特征.
- 通过在异质网络上的多模态深度自编码器构建一个深度特征表示药物网络.
- 使用注意力从药物网络转移到药物疾病相互作用网络的药物疾病关联预测.
主要成果:
- 拟议的ATDR方法在综合性实验中,与基线方法相比,表现优越.
- ATDR有效地整合了来自异质生物网络的特征,以改善药物重新定位.
- 预测潜在的药物与疾病的相互作用可以显著帮助开发各种疾病的治疗方法.
结论:
- 通过有效利用异质网络信息,ATDR为计算药物重新定位提供了一个有希望的方法.
- 注意转移机制提高了药物疾病关联预测的准确性.
- 这种方法有可能加速药物开发管道,并改善复杂疾病的治疗策略.
相关概念视频
Drug Discovery: Overview
7.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.5K
Drug-Receptor Interactions
5.0K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.0K
Targets for Drug Action: Overview
6.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.1K
Drug Biotransformation: Overview
2.3K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.3K
Drug-Receptor Interaction: Agonist
2.4K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.4K
Drug-Receptor Interaction: Antagonist
2.8K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
2.8K


